Gemcitabine resistance in breast cancer cells regulated by PI3K/AKT-mediated cellular proliferation exerts negative feedback via the MEK/MAPK and mTOR pathways
Zhou Luo Ou(Fudan University Shanghai Cancer Center), Zhi Min Shao(Fudan University Shanghai Cancer Center)
Cited by 52
Related Papers
CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis
|Oncology Reports|2017|76
The role of the chemokine receptor XCR1 in breast cancer cells
|Breast Cancer Targets and Therapy|2017|19